Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related 		KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Adipocytokine signaling pathway 💬
 1件: JAK2 💬 Baricitinib 💬 Baricitinib 24件:  2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬
2 Adipocytokine signaling pathway 💬
 1件: JAK2 💬 Tofacitinib citrate 💬 Tofacitinib 23件:  2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
3 Adipocytokine signaling pathway 💬
 1件: JAK2 💬 Tofacitinib 💬 Tofacitinib 23件:  2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
4 Adipocytokine signaling pathway 💬
 1件: TNF 💬 Adalimumab 💬 Adalimumab 22件: 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
5 Adipocytokine signaling pathway 💬
 1件: TNF 💬 Certolizumab pegol 💬 Certolizumab pegol 10件: 37, 40, 46, 48, 49, 96, 97, 107, 226, 271 💬
6 Adipocytokine signaling pathway 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
7 Adipocytokine signaling pathway 💬
 1件: TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
8 African trypanosomiasis 💬
 4件: IL10, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
9 African trypanosomiasis 💬
 2件: IL12A, IL12B 💬 Ustekinumab 💬 Ustekinumab 17件: 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
10 African trypanosomiasis 💬
 1件: TNF 💬 Adalimumab 💬 Adalimumab 22件: 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
11 African trypanosomiasis 💬
 1件: TNF 💬 Certolizumab pegol 💬 Certolizumab pegol 10件: 37, 40, 46, 48, 49, 96, 97, 107, 226, 271 💬
12 African trypanosomiasis 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
13 AGE-RAGE signaling pathway in diabetic complications 💬
 5件: CCL2, IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
14 AGE-RAGE signaling pathway in diabetic complications 💬
 1件: JAK2 💬 Baricitinib 💬 Baricitinib 24件:  2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬
15 AGE-RAGE signaling pathway in diabetic complications 💬
 1件: JAK2 💬 Tofacitinib citrate 💬 Tofacitinib 23件:  2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
16 AGE-RAGE signaling pathway in diabetic complications 💬
 1件: JAK2 💬 Tofacitinib 💬 Tofacitinib 23件:  2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
17 AGE-RAGE signaling pathway in diabetic complications 💬
 1件: TNF 💬 Adalimumab 💬 Adalimumab 22件: 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
18 AGE-RAGE signaling pathway in diabetic complications 💬
 1件: TNF 💬 Certolizumab pegol 💬 Certolizumab pegol 10件: 37, 40, 46, 48, 49, 96, 97, 107, 226, 271 💬
19 AGE-RAGE signaling pathway in diabetic complications 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
20 Alcoholic liver disease 💬
 2件: IL12A, IL12B 💬 Ustekinumab 💬 Ustekinumab 17件: 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
21 Alcoholic liver disease 💬
 1件: IL17A 💬 Secukinumab 💬 Secukinumab 9件: 13, 37, 40, 41, 46, 107, 160, 269, 271 💬
22 Alcoholic liver disease 💬
 3件: IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
23 Alcoholic liver disease 💬
 1件: TNF 💬 Adalimumab 💬 Adalimumab 22件: 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
24 Alcoholic liver disease 💬
 1件: TNF 💬 Certolizumab pegol 💬 Certolizumab pegol 10件: 37, 40, 46, 48, 49, 96, 97, 107, 226, 271 💬
25 Alcoholic liver disease 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
26 Allograft rejection 💬
 2件: IL10, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
27 Allograft rejection 💬
 2件: IL12A, IL12B 💬 Ustekinumab 💬 Ustekinumab 17件: 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
28 Allograft rejection 💬
 1件: TNF 💬 Adalimumab 💬 Adalimumab 22件: 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
29 Allograft rejection 💬
 1件: TNF 💬 Certolizumab pegol 💬 Certolizumab pegol 10件: 37, 40, 46, 48, 49, 96, 97, 107, 226, 271 💬
30 Allograft rejection 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
31 Alzheimer disease 💬
 4件: IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
32 Alzheimer disease 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Cyclosporine 💬 Cyclosporine 39件: 11, 14, 19, 20, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 67, 90, 95, 97, 107, 118, 162, 164, 222, 223, 226, 228, 234, 283, 284, 285, 302 💬
33 Alzheimer disease 💬
 1件: TNF 💬 Adalimumab 💬 Adalimumab 22件: 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
34 Alzheimer disease 💬
 1件: TNF 💬 Certolizumab pegol 💬 Certolizumab pegol 10件: 37, 40, 46, 48, 49, 96, 97, 107, 226, 271 💬
35 Alzheimer disease 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
36 Amoebiasis 💬
 4件: IL10, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
37 Amoebiasis 💬
 2件: IL12A, IL12B 💬 Ustekinumab 💬 Ustekinumab 17件: 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
38 Amoebiasis 💬
 1件: TNF 💬 Adalimumab 💬 Adalimumab 22件: 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
39 Amoebiasis 💬
 1件: TNF 💬 Certolizumab pegol 💬 Certolizumab pegol 10件: 37, 40, 46, 48, 49, 96, 97, 107, 226, 271 💬
40 Amoebiasis 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
41 Amphetamine addiction 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Cyclosporine 💬 Cyclosporine 39件: 11, 14, 19, 20, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 67, 90, 95, 97, 107, 118, 162, 164, 222, 223, 226, 228, 234, 283, 284, 285, 302 💬
42 Amyotrophic lateral sclerosis 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Cyclosporine 💬 Cyclosporine 39件: 11, 14, 19, 20, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 67, 90, 95, 97, 107, 118, 162, 164, 222, 223, 226, 228, 234, 283, 284, 285, 302 💬
43 Amyotrophic lateral sclerosis 💬
 1件: TNF 💬 Adalimumab 💬 Adalimumab 22件: 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
44 Amyotrophic lateral sclerosis 💬
 1件: TNF 💬 Certolizumab pegol 💬 Certolizumab pegol 10件: 37, 40, 46, 48, 49, 96, 97, 107, 226, 271 💬
45 Amyotrophic lateral sclerosis 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
46 Amyotrophic lateral sclerosis 💬
 1件: TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
47 Antigen processing and presentation 💬
 1件: TNF 💬 Adalimumab 💬 Adalimumab 22件: 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
48 Antigen processing and presentation 💬
 1件: TNF 💬 Certolizumab pegol 💬 Certolizumab pegol 10件: 37, 40, 46, 48, 49, 96, 97, 107, 226, 271 💬
49 Antigen processing and presentation 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
50 Antigen processing and presentation 💬
 1件: TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
51 Apoptosis 💬
 1件: TNF 💬 Adalimumab 💬 Adalimumab 22件: 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
52 Apoptosis 💬
 1件: TNF 💬 Certolizumab pegol 💬 Certolizumab pegol 10件: 37, 40, 46, 48, 49, 96, 97, 107, 226, 271 💬
53 Apoptosis 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
54 Apoptosis 💬
 1件: TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
55 Asthma 💬
 2件: IL10, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
56 Asthma 💬
 1件: TNF 💬 Adalimumab 💬 Adalimumab 22件: 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
57 Asthma 💬
 1件: TNF 💬 Certolizumab pegol 💬 Certolizumab pegol 10件: 37, 40, 46, 48, 49, 96, 97, 107, 226, 271 💬
58 Asthma 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
59 Autoimmune thyroid disease 💬
 1件: IL10 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
60 Axon guidance 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Cyclosporine 💬 Cyclosporine 39件: 11, 14, 19, 20, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 67, 90, 95, 97, 107, 118, 162, 164, 222, 223, 226, 228, 234, 283, 284, 285, 302 💬
61 B cell receptor signaling pathway 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Cyclosporine 💬 Cyclosporine 39件: 11, 14, 19, 20, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 67, 90, 95, 97, 107, 118, 162, 164, 222, 223, 226, 228, 234, 283, 284, 285, 302 💬
62 C-type lectin receptor signaling pathway 💬
 4件: IL10, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
63 C-type lectin receptor signaling pathway 💬
 3件: IL12A, IL12B, IL23A 💬 Ustekinumab 💬 Ustekinumab 17件: 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
64 C-type lectin receptor signaling pathway 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Cyclosporine 💬 Cyclosporine 39件: 11, 14, 19, 20, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 67, 90, 95, 97, 107, 118, 162, 164, 222, 223, 226, 228, 234, 283, 284, 285, 302 💬
65 C-type lectin receptor signaling pathway 💬
 1件: TNF 💬 Adalimumab 💬 Adalimumab 22件: 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
66 C-type lectin receptor signaling pathway 💬
 1件: TNF 💬 Certolizumab pegol 💬 Certolizumab pegol 10件: 37, 40, 46, 48, 49, 96, 97, 107, 226, 271 💬
67 C-type lectin receptor signaling pathway 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
68 Calcium signaling pathway 💬
 2件: EDNRA, EDNRB 💬 Bosentan 💬 Bosentan 12件: 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
69 Calcium signaling pathway 💬
 2件: EDNRA, EDNRB 💬 Bosentan 💬 Bosentan 12件: 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
70 Calcium signaling pathway 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Cyclosporine 💬 Cyclosporine 39件: 11, 14, 19, 20, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 67, 90, 95, 97, 107, 118, 162, 164, 222, 223, 226, 228, 234, 283, 284, 285, 302 💬
71 cAMP signaling pathway 💬
 1件: EDNRA 💬 Bosentan 💬 Bosentan 12件: 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
72 cAMP signaling pathway 💬
 1件: EDNRA 💬 Bosentan 💬 Bosentan 12件: 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
73 Cellular senescence 💬
 2件: IL1A, IL6 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
74 Cellular senescence 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Cyclosporine 💬 Cyclosporine 39件: 11, 14, 19, 20, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 67, 90, 95, 97, 107, 118, 162, 164, 222, 223, 226, 228, 234, 283, 284, 285, 302 💬
75 cGMP-PKG signaling pathway 💬
 2件: EDNRA, EDNRB 💬 Bosentan 💬 Bosentan 12件: 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
76 cGMP-PKG signaling pathway 💬
 2件: EDNRA, EDNRB 💬 Bosentan 💬 Bosentan 12件: 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
77 cGMP-PKG signaling pathway 💬
 1件: OPRD1 💬 Naltrexone hydrochloride 💬 Naltrexone 14件:  6 , 10, 13, 40, 41, 42, 43, 44, 45, 46, 49, 96, 97, 226 💬
78 cGMP-PKG signaling pathway 💬
 1件: OPRD1 💬 Naltrexone 💬 Naltrexone 14件:  6 , 10, 13, 40, 41, 42, 43, 44, 45, 46, 49, 96, 97, 226 💬
79 cGMP-PKG signaling pathway 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Cyclosporine 💬 Cyclosporine 39件: 11, 14, 19, 20, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 67, 90, 95, 97, 107, 118, 162, 164, 222, 223, 226, 228, 234, 283, 284, 285, 302 💬
80 Chagas disease 💬
 5件: CCL2, IL10, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
81 Chagas disease 💬
 2件: IL12A, IL12B 💬 Ustekinumab 💬 Ustekinumab 17件: 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
82 Chagas disease 💬
 1件: TNF 💬 Adalimumab 💬 Adalimumab 22件: 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
83 Chagas disease 💬
 1件: TNF 💬 Certolizumab pegol 💬 Certolizumab pegol 10件: 37, 40, 46, 48, 49, 96, 97, 107, 226, 271 💬
84 Chagas disease 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
85 Chemical carcinogenesis - receptor activation 💬
 1件: JAK2 💬 Baricitinib 💬 Baricitinib 24件:  2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬
86 Chemical carcinogenesis - receptor activation 💬
 1件: JAK2 💬 Tofacitinib citrate 💬 Tofacitinib 23件:  2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
87 Chemical carcinogenesis - receptor activation 💬
 1件: JAK2 💬 Tofacitinib 💬 Tofacitinib 23件:  2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
88 Chemokine signaling pathway 💬
 1件: CCL2 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
89 Chemokine signaling pathway 💬
 1件: JAK2 💬 Baricitinib 💬 Baricitinib 24件:  2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬
90 Chemokine signaling pathway 💬
 2件: JAK2, JAK3 💬 Tofacitinib citrate 💬 Tofacitinib 23件:  2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
91 Chemokine signaling pathway 💬
 2件: JAK2, JAK3 💬 Tofacitinib 💬 Tofacitinib 23件:  2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
92 Cholinergic synapse 💬
 1件: JAK2 💬 Baricitinib 💬 Baricitinib 24件:  2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬
93 Cholinergic synapse 💬
 1件: JAK2 💬 Tofacitinib citrate 💬 Tofacitinib 23件:  2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
94 Cholinergic synapse 💬
 1件: JAK2 💬 Tofacitinib 💬 Tofacitinib 23件:  2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
95 Coronavirus disease 💬
 4件: CCL2, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
96 Coronavirus disease 💬
 2件: IL12A, IL12B 💬 Ustekinumab 💬 Ustekinumab 17件: 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
97 Coronavirus disease 💬
 1件: IL6R 💬 Tocilizumab 💬 Tocilizumab 26件:  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 65, 86, 107, 149, 153, 223, 266, 271, 298, 331 💬
98 Coronavirus disease 💬
 1件: JAK1 💬 Baricitinib 💬 Baricitinib 24件:  2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬
99 Coronavirus disease 💬
 1件: JAK1 💬 Ivarmacitinib 💬 Ivarmacitinib 6件: 40, 46, 51, 56, 271, 300 💬
100 Coronavirus disease 💬
 1件: JAK1 💬 Ivarmacitinib sulfate 💬 Ivarmacitinib 6件: 40, 46, 51, 56, 271, 300 💬
101 Coronavirus disease 💬
 1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
102 Coronavirus disease 💬
 1件: JAK1 💬 Upadacitinib tartrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
103 Coronavirus disease 💬
 1件: JAK1 💬 Upadacitinib hydrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
104 Coronavirus disease 💬
 2件: JAK1, TYK2 💬 Tofacitinib citrate 💬 Tofacitinib 23件:  2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
105 Coronavirus disease 💬
 2件: JAK1, TYK2 💬 Tofacitinib 💬 Tofacitinib 23件:  2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
106 Coronavirus disease 💬
 1件: TNF 💬 Adalimumab 💬 Adalimumab 22件: 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
107 Coronavirus disease 💬
 1件: TNF 💬 Certolizumab pegol 💬 Certolizumab pegol 10件: 37, 40, 46, 48, 49, 96, 97, 107, 226, 271 💬
108 Coronavirus disease 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
109 Coronavirus disease 💬
 1件: TYK2 💬 Deucravacitinib 💬 Deucravacitinib 10件: 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬
110 Cytokine-cytokine receptor interaction 💬
 6件: CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
111 Cytokine-cytokine receptor interaction 💬
 1件: CSF3R 💬 Filgrastim 💬 Filgrastim 30件:  2 ,  6 , 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 63, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
112 Cytokine-cytokine receptor interaction 💬
 3件: IL12A, IL12B, IL23A 💬 Ustekinumab 💬 Ustekinumab 17件: 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
113 Cytokine-cytokine receptor interaction 💬
 1件: IL17A 💬 Secukinumab 💬 Secukinumab 9件: 13, 37, 40, 41, 46, 107, 160, 269, 271 💬
114 Cytokine-cytokine receptor interaction 💬
 1件: IL6R 💬 Tocilizumab 💬 Tocilizumab 26件:  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 65, 86, 107, 149, 153, 223, 266, 271, 298, 331 💬
115 Cytokine-cytokine receptor interaction 💬
 1件: TNF 💬 Adalimumab 💬 Adalimumab 22件: 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
116 Cytokine-cytokine receptor interaction 💬
 1件: TNF 💬 Certolizumab pegol 💬 Certolizumab pegol 10件: 37, 40, 46, 48, 49, 96, 97, 107, 226, 271 💬
117 Cytokine-cytokine receptor interaction 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
118 Cytosolic DNA-sensing pathway 💬
 2件: IL1B, IL6 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
119 Dilated cardiomyopathy 💬
 1件: TNF 💬 Adalimumab 💬 Adalimumab 22件: 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
120 Dilated cardiomyopathy 💬
 1件: TNF 💬 Certolizumab pegol 💬 Certolizumab pegol 10件: 37, 40, 46, 48, 49, 96, 97, 107, 226, 271 💬
121 Dilated cardiomyopathy 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
122 Dilated cardiomyopathy 💬
 1件: TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
123 DNA replication 💬
 2件: POLA1, POLA2 💬 Clofarabine 💬 Clofarabine 9件: 19, 20, 40, 46, 49, 60, 96, 234, 326 💬
124 Dopaminergic synapse 💬
 3件: PPP3CA, PPP3CB, PPP3CC 💬 Cyclosporine 💬 Cyclosporine 39件: 11, 14, 19, 20, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 67, 90, 95, 97, 107, 118, 162, 164, 222, 223, 226, 228, 234, 283, 284, 285, 302 💬
125 Drug metabolism - other enzymes 💬
 1件: RRM1 💬 Clofarabine 💬 Clofarabine 9件: 19, 20, 40, 46, 49, 60, 96, 234, 326 💬
126 Efferocytosis 💬
 1件: IL10 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
127 Efferocytosis 💬
 1件: JAK2 💬 Baricitinib 💬 Baricitinib 24件:  2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬
128 Efferocytosis 💬
 1件: JAK2 💬 Tofacitinib citrate 💬 Tofacitinib 23件:  2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
129 Efferocytosis 💬
 1件: JAK2 💬 Tofacitinib 💬 Tofacitinib 23件:  2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
130 Efferocytosis 💬
 1件: P2RY12 💬 Clopidogrel bisulfate 💬 Clopidogrel 7件: 40, 49, 51, 62, 71, 86, 222 💬
131 Efferocytosis 💬
 1件: P2RY12 💬 Clopidogrel 💬 Clopidogrel 7件: 40, 49, 51, 62, 71, 86, 222 💬
132 Efferocytosis 💬
 1件: P2RY12 💬 Clopidogrel hydrochloride 💬 Clopidogrel 7件: 40, 49, 51, 62, 71, 86, 222 💬
133 Efferocytosis 💬
 1件: P2RY12 💬 Clopidogrel besilate 💬 Clopidogrel 7件: 40, 49, 51, 62, 71, 86, 222 💬
134 Epstein-Barr virus infection 💬
 2件: IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
135 Epstein-Barr virus infection 💬
 1件: JAK1 💬 Baricitinib 💬 Baricitinib 24件:  2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬
136 Epstein-Barr virus infection 💬
 1件: JAK1 💬 Ivarmacitinib 💬 Ivarmacitinib 6件: 40, 46, 51, 56, 271, 300 💬
137 Epstein-Barr virus infection 💬
 1件: JAK1 💬 Ivarmacitinib sulfate 💬 Ivarmacitinib 6件: 40, 46, 51, 56, 271, 300 💬
138 Epstein-Barr virus infection 💬
 1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
139 Epstein-Barr virus infection 💬
 1件: JAK1 💬 Upadacitinib tartrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
140 Epstein-Barr virus infection 💬
 1件: JAK1 💬 Upadacitinib hydrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
141 Epstein-Barr virus infection 💬
 3件: JAK1, JAK3, TYK2 💬 Tofacitinib citrate 💬 Tofacitinib 23件:  2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
142 Epstein-Barr virus infection 💬
 3件: JAK1, JAK3, TYK2 💬 Tofacitinib 💬 Tofacitinib 23件:  2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
143 Epstein-Barr virus infection 💬
 1件: TNF 💬 Adalimumab 💬 Adalimumab 22件: 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
144 Epstein-Barr virus infection 💬
 1件: TNF 💬 Certolizumab pegol 💬 Certolizumab pegol 10件: 37, 40, 46, 48, 49, 96, 97, 107, 226, 271 💬
145 Epstein-Barr virus infection 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
146 Epstein-Barr virus infection 💬
 1件: TYK2 💬 Deucravacitinib 💬 Deucravacitinib 10件: 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬
147 Estrogen signaling pathway 💬
 1件: OPRM1 💬 Naltrexone hydrochloride 💬 Naltrexone 14件:  6 , 10, 13, 40, 41, 42, 43, 44, 45, 46, 49, 96, 97, 226 💬
148 Estrogen signaling pathway 💬
 1件: OPRM1 💬 Naltrexone 💬 Naltrexone 14件:  6 , 10, 13, 40, 41, 42, 43, 44, 45, 46, 49, 96, 97, 226 💬
149 Fc epsilon RI signaling pathway 💬
 1件: TNF 💬 Adalimumab 💬 Adalimumab 22件: 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
150 Fc epsilon RI signaling pathway 💬
 1件: TNF 💬 Certolizumab pegol 💬 Certolizumab pegol 10件: 37, 40, 46, 48, 49, 96, 97, 107, 226, 271 💬
151 Fc epsilon RI signaling pathway 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
152 Fc epsilon RI signaling pathway 💬
 1件: TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
153 Fluid shear stress and atherosclerosis 💬
 4件: CCL2, IL1A, IL1B, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
154 Fluid shear stress and atherosclerosis 💬
 1件: TNF 💬 Adalimumab 💬 Adalimumab 22件: 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
155 Fluid shear stress and atherosclerosis 💬
 1件: TNF 💬 Certolizumab pegol 💬 Certolizumab pegol 10件: 37, 40, 46, 48, 49, 96, 97, 107, 226, 271 💬
156 Fluid shear stress and atherosclerosis 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
157 Folate biosynthesis 💬
 2件: DHFR, DHFR2 💬 Methotrexate 💬 Methotrexate 41件: 11, 13, 14, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 223, 240, 256, 270, 271, 284, 285, 286, 326, 331 💬
158 Folate biosynthesis 💬
 2件: DHFR, DHFR2 💬 Methotrexate sodium 💬 Methotrexate 41件: 11, 13, 14, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 223, 240, 256, 270, 271, 284, 285, 286, 326, 331 💬
159 Folate transport and metabolism 💬
 2件: DHFR, DHFR2 💬 Methotrexate 💬 Methotrexate 41件: 11, 13, 14, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 223, 240, 256, 270, 271, 284, 285, 286, 326, 331 💬
160 Folate transport and metabolism 💬
 2件: DHFR, DHFR2 💬 Methotrexate sodium 💬 Methotrexate 41件: 11, 13, 14, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 223, 240, 256, 270, 271, 284, 285, 286, 326, 331 💬
161 FoxO signaling pathway 💬
 2件: IL10, IL6 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
162 Glucagon signaling pathway 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Cyclosporine 💬 Cyclosporine 39件: 11, 14, 19, 20, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 67, 90, 95, 97, 107, 118, 162, 164, 222, 223, 226, 228, 234, 283, 284, 285, 302 💬
163 Glutamatergic synapse 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Cyclosporine 💬 Cyclosporine 39件: 11, 14, 19, 20, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 67, 90, 95, 97, 107, 118, 162, 164, 222, 223, 226, 228, 234, 283, 284, 285, 302 💬
164 Glutathione metabolism 💬
 1件: RRM1 💬 Clofarabine 💬 Clofarabine 9件: 19, 20, 40, 46, 49, 60, 96, 234, 326 💬
165 Graft-versus-host disease 💬
 4件: IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
166 Graft-versus-host disease 💬
 1件: TNF 💬 Adalimumab 💬 Adalimumab 22件: 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
167 Graft-versus-host disease 💬
 1件: TNF 💬 Certolizumab pegol 💬 Certolizumab pegol 10件: 37, 40, 46, 48, 49, 96, 97, 107, 226, 271 💬
168 Graft-versus-host disease 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
169 Growth hormone synthesis, secretion and action 💬
 1件: JAK2 💬 Baricitinib 💬 Baricitinib 24件:  2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬
170 Growth hormone synthesis, secretion and action 💬
 1件: JAK2 💬 Tofacitinib citrate 💬 Tofacitinib 23件:  2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
171 Growth hormone synthesis, secretion and action 💬
 1件: JAK2 💬 Tofacitinib 💬 Tofacitinib 23件:  2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
172 Hematopoietic cell lineage 💬
 1件: CSF3R 💬 Filgrastim 💬 Filgrastim 30件:  2 ,  6 , 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 63, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
173 Hematopoietic cell lineage 💬
 4件: IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
174 Hematopoietic cell lineage 💬
 1件: IL6R 💬 Tocilizumab 💬 Tocilizumab 26件:  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 65, 86, 107, 149, 153, 223, 266, 271, 298, 331 💬
175 Hematopoietic cell lineage 💬
 1件: MS4A1 💬 Rituximab 💬 Rituximab 54件: 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 88, 93, 94, 96, 97, 162, 172, 222, 223, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
176 Hematopoietic cell lineage 💬
 1件: TNF 💬 Adalimumab 💬 Adalimumab 22件: 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
177 Hematopoietic cell lineage 💬
 1件: TNF 💬 Certolizumab pegol 💬 Certolizumab pegol 10件: 37, 40, 46, 48, 49, 96, 97, 107, 226, 271 💬
178 Hematopoietic cell lineage 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
179 Hepatitis B 💬
 2件: IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
180 Hepatitis B 💬
 1件: JAK1 💬 Ivarmacitinib 💬 Ivarmacitinib 6件: 40, 46, 51, 56, 271, 300 💬
181 Hepatitis B 💬
 1件: JAK1 💬 Ivarmacitinib sulfate 💬 Ivarmacitinib 6件: 40, 46, 51, 56, 271, 300 💬
182 Hepatitis B 💬
 1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
183 Hepatitis B 💬
 1件: JAK1 💬 Upadacitinib tartrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
184 Hepatitis B 💬
 1件: JAK1 💬 Upadacitinib hydrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
185 Hepatitis B 💬
 2件: JAK1, JAK2 💬 Baricitinib 💬 Baricitinib 24件:  2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬
186 Hepatitis B 💬
 4件: JAK1, JAK2, JAK3, TYK2 💬 Tofacitinib citrate 💬 Tofacitinib 23件:  2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
187 Hepatitis B 💬
 4件: JAK1, JAK2, JAK3, TYK2 💬 Tofacitinib 💬 Tofacitinib 23件:  2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
188 Hepatitis B 💬
 1件: TNF 💬 Adalimumab 💬 Adalimumab 22件: 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
189 Hepatitis B 💬
 1件: TNF 💬 Certolizumab pegol 💬 Certolizumab pegol 10件: 37, 40, 46, 48, 49, 96, 97, 107, 226, 271 💬
190 Hepatitis B 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
191 Hepatitis B 💬
 1件: TYK2 💬 Deucravacitinib 💬 Deucravacitinib 10件: 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬
192 Hepatitis C 💬
 1件: JAK1 💬 Baricitinib 💬 Baricitinib 24件:  2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬
193 Hepatitis C 💬
 1件: JAK1 💬 Ivarmacitinib 💬 Ivarmacitinib 6件: 40, 46, 51, 56, 271, 300 💬
194 Hepatitis C 💬
 1件: JAK1 💬 Ivarmacitinib sulfate 💬 Ivarmacitinib 6件: 40, 46, 51, 56, 271, 300 💬
195 Hepatitis C 💬
 1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
196 Hepatitis C 💬
 1件: JAK1 💬 Upadacitinib tartrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
197 Hepatitis C 💬
 1件: JAK1 💬 Upadacitinib hydrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
198 Hepatitis C 💬
 2件: JAK1, TYK2 💬 Tofacitinib citrate 💬 Tofacitinib 23件:  2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
199 Hepatitis C 💬
 2件: JAK1, TYK2 💬 Tofacitinib 💬 Tofacitinib 23件:  2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
200 Hepatitis C 💬
 1件: TNF 💬 Adalimumab 💬 Adalimumab 22件: 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
201 Hepatitis C 💬
 1件: TNF 💬 Certolizumab pegol 💬 Certolizumab pegol 10件: 37, 40, 46, 48, 49, 96, 97, 107, 226, 271 💬
202 Hepatitis C 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
203 Hepatitis C 💬
 1件: TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
204 Hepatitis C 💬
 1件: TYK2 💬 Deucravacitinib 💬 Deucravacitinib 10件: 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬
205 Herpes simplex virus 1 infection 💬
 4件: CCL2, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
206 Herpes simplex virus 1 infection 💬
 2件: IL12A, IL12B 💬 Ustekinumab 💬 Ustekinumab 17件: 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
207 Herpes simplex virus 1 infection 💬
 1件: JAK1 💬 Ivarmacitinib 💬 Ivarmacitinib 6件: 40, 46, 51, 56, 271, 300 💬
208 Herpes simplex virus 1 infection 💬
 1件: JAK1 💬 Ivarmacitinib sulfate 💬 Ivarmacitinib 6件: 40, 46, 51, 56, 271, 300 💬
209 Herpes simplex virus 1 infection 💬
 1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
210 Herpes simplex virus 1 infection 💬
 1件: JAK1 💬 Upadacitinib tartrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
211 Herpes simplex virus 1 infection 💬
 1件: JAK1 💬 Upadacitinib hydrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
212 Herpes simplex virus 1 infection 💬
 2件: JAK1, JAK2 💬 Baricitinib 💬 Baricitinib 24件:  2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬
213 Herpes simplex virus 1 infection 💬
 3件: JAK1, JAK2, TYK2 💬 Tofacitinib citrate 💬 Tofacitinib 23件:  2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
214 Herpes simplex virus 1 infection 💬
 3件: JAK1, JAK2, TYK2 💬 Tofacitinib 💬 Tofacitinib 23件:  2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
215 Herpes simplex virus 1 infection 💬
 1件: TNF 💬 Adalimumab 💬 Adalimumab 22件: 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
216 Herpes simplex virus 1 infection 💬
 1件: TNF 💬 Certolizumab pegol 💬 Certolizumab pegol 10件: 37, 40, 46, 48, 49, 96, 97, 107, 226, 271 💬
217 Herpes simplex virus 1 infection 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
218 Herpes simplex virus 1 infection 💬
 1件: TYK2 💬 Deucravacitinib 💬 Deucravacitinib 10件: 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬
219 HIF-1 signaling pathway 💬
 1件: IL6 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
220 HIF-1 signaling pathway 💬
 1件: IL6R 💬 Tocilizumab 💬 Tocilizumab 26件:  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 65, 86, 107, 149, 153, 223, 266, 271, 298, 331 💬
221 Hormone signaling 💬
 1件: JAK2 💬 Baricitinib 💬 Baricitinib 24件:  2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬
222 Hormone signaling 💬
 1件: JAK2 💬 Tofacitinib citrate 💬 Tofacitinib 23件:  2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
223 Hormone signaling 💬
 1件: JAK2 💬 Tofacitinib 💬 Tofacitinib 23件:  2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
224 Hormone signaling 💬
 3件: OPRD1, OPRK1, OPRM1 💬 Naltrexone hydrochloride 💬 Naltrexone 14件:  6 , 10, 13, 40, 41, 42, 43, 44, 45, 46, 49, 96, 97, 226 💬
225 Hormone signaling 💬
 3件: OPRD1, OPRK1, OPRM1 💬 Naltrexone 💬 Naltrexone 14件:  6 , 10, 13, 40, 41, 42, 43, 44, 45, 46, 49, 96, 97, 226 💬
226 Human cytomegalovirus infection 💬
 4件: CCL2, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
227 Human cytomegalovirus infection 💬
 1件: IL6R 💬 Tocilizumab 💬 Tocilizumab 26件:  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 65, 86, 107, 149, 153, 223, 266, 271, 298, 331 💬
228 Human cytomegalovirus infection 💬
 1件: JAK1 💬 Baricitinib 💬 Baricitinib 24件:  2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬
229 Human cytomegalovirus infection 💬
 1件: JAK1 💬 Ivarmacitinib 💬 Ivarmacitinib 6件: 40, 46, 51, 56, 271, 300 💬
230 Human cytomegalovirus infection 💬
 1件: JAK1 💬 Ivarmacitinib sulfate 💬 Ivarmacitinib 6件: 40, 46, 51, 56, 271, 300 💬
231 Human cytomegalovirus infection 💬
 1件: JAK1 💬 Tofacitinib citrate 💬 Tofacitinib 23件:  2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
232 Human cytomegalovirus infection 💬
 1件: JAK1 💬 Tofacitinib 💬 Tofacitinib 23件:  2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
233 Human cytomegalovirus infection 💬
 1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
234 Human cytomegalovirus infection 💬
 1件: JAK1 💬 Upadacitinib tartrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
235 Human cytomegalovirus infection 💬
 1件: JAK1 💬 Upadacitinib hydrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
236 Human cytomegalovirus infection 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Cyclosporine 💬 Cyclosporine 39件: 11, 14, 19, 20, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 67, 90, 95, 97, 107, 118, 162, 164, 222, 223, 226, 228, 234, 283, 284, 285, 302 💬
237 Human cytomegalovirus infection 💬
 1件: TNF 💬 Adalimumab 💬 Adalimumab 22件: 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
238 Human cytomegalovirus infection 💬
 1件: TNF 💬 Certolizumab pegol 💬 Certolizumab pegol 10件: 37, 40, 46, 48, 49, 96, 97, 107, 226, 271 💬
239 Human cytomegalovirus infection 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
240 Human immunodeficiency virus 1 infection 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Cyclosporine 💬 Cyclosporine 39件: 11, 14, 19, 20, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 67, 90, 95, 97, 107, 118, 162, 164, 222, 223, 226, 228, 234, 283, 284, 285, 302 💬
241 Human immunodeficiency virus 1 infection 💬
 1件: TNF 💬 Adalimumab 💬 Adalimumab 22件: 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
242 Human immunodeficiency virus 1 infection 💬
 1件: TNF 💬 Certolizumab pegol 💬 Certolizumab pegol 10件: 37, 40, 46, 48, 49, 96, 97, 107, 226, 271 💬
243 Human immunodeficiency virus 1 infection 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
244 Human immunodeficiency virus 1 infection 💬
 1件: TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
245 Human papillomavirus infection 💬
 1件: JAK1 💬 Baricitinib 💬 Baricitinib 24件:  2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬
246 Human papillomavirus infection 💬
 1件: JAK1 💬 Ivarmacitinib 💬 Ivarmacitinib 6件: 40, 46, 51, 56, 271, 300 💬
247 Human papillomavirus infection 💬
 1件: JAK1 💬 Ivarmacitinib sulfate 💬 Ivarmacitinib 6件: 40, 46, 51, 56, 271, 300 💬
248 Human papillomavirus infection 💬
 1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
249 Human papillomavirus infection 💬
 1件: JAK1 💬 Upadacitinib tartrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
250 Human papillomavirus infection 💬
 1件: JAK1 💬 Upadacitinib hydrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
251 Human papillomavirus infection 💬
 2件: JAK1, TYK2 💬 Tofacitinib citrate 💬 Tofacitinib 23件:  2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
252 Human papillomavirus infection 💬
 2件: JAK1, TYK2 💬 Tofacitinib 💬 Tofacitinib 23件:  2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
253 Human papillomavirus infection 💬
 1件: TNF 💬 Adalimumab 💬 Adalimumab 22件: 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
254 Human papillomavirus infection 💬
 1件: TNF 💬 Certolizumab pegol 💬 Certolizumab pegol 10件: 37, 40, 46, 48, 49, 96, 97, 107, 226, 271 💬
255 Human papillomavirus infection 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
256 Human papillomavirus infection 💬
 1件: TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
257 Human papillomavirus infection 💬
 1件: TYK2 💬 Deucravacitinib 💬 Deucravacitinib 10件: 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬
258 Human T-cell leukemia virus 1 infection 💬
 2件: IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
259 Human T-cell leukemia virus 1 infection 💬
 1件: JAK1 💬 Baricitinib 💬 Baricitinib 24件:  2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬
260 Human T-cell leukemia virus 1 infection 💬
 1件: JAK1 💬 Ivarmacitinib 💬 Ivarmacitinib 6件: 40, 46, 51, 56, 271, 300 💬
261 Human T-cell leukemia virus 1 infection 💬
 1件: JAK1 💬 Ivarmacitinib sulfate 💬 Ivarmacitinib 6件: 40, 46, 51, 56, 271, 300 💬
262 Human T-cell leukemia virus 1 infection 💬
 1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
263 Human T-cell leukemia virus 1 infection 💬
 1件: JAK1 💬 Upadacitinib tartrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
264 Human T-cell leukemia virus 1 infection 💬
 1件: JAK1 💬 Upadacitinib hydrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
265 Human T-cell leukemia virus 1 infection 💬
 2件: JAK1, JAK3 💬 Tofacitinib citrate 💬 Tofacitinib 23件:  2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
266 Human T-cell leukemia virus 1 infection 💬
 2件: JAK1, JAK3 💬 Tofacitinib 💬 Tofacitinib 23件:  2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
267 Human T-cell leukemia virus 1 infection 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 Cyclosporine 💬 Cyclosporine 39件: 11, 14, 19, 20, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 67, 90, 95, 97, 107, 118, 162, 164, 222, 223, 226, 228, 234, 283, 284, 285, 302 💬
268 Human T-cell leukemia virus 1 infection 💬
 1件: TNF 💬 Adalimumab 💬 Adalimumab 22件: 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
269 Human T-cell leukemia virus 1 infection 💬
 1件: TNF 💬 Certolizumab pegol 💬 Certolizumab pegol 10件: 37, 40, 46, 48, 49, 96, 97, 107, 226, 271 💬
270 Human T-cell leukemia virus 1 infection 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
271 Hypertrophic cardiomyopathy 💬
 2件: IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
272 Hypertrophic cardiomyopathy 💬
 1件: TNF 💬 Adalimumab 💬 Adalimumab 22件: 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
273 Hypertrophic cardiomyopathy 💬
 1件: TNF 💬 Certolizumab pegol 💬 Certolizumab pegol 10件: 37, 40, 46, 48, 49, 96, 97, 107, 226, 271 💬
274 Hypertrophic cardiomyopathy 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
275 IL-17 signaling pathway 💬
 4件: CCL2, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
276 IL-17 signaling pathway 💬
 1件: IL17A 💬 Secukinumab 💬 Secukinumab 9件: 13, 37, 40, 41, 46, 107, 160, 269, 271 💬
277 IL-17 signaling pathway 💬
 1件: TNF 💬 Adalimumab 💬 Adalimumab 22件: 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
278 IL-17 signaling pathway 💬
 1件: TNF 💬 Certolizumab pegol 💬 Certolizumab pegol 10件: 37, 40, 46, 48, 49, 96, 97, 107, 226, 271 💬
279 IL-17 signaling pathway 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
280 Inflammatory bowel disease 💬
 5件: IL10, IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
281 Inflammatory bowel disease 💬
 3件: IL12A, IL12B, IL23A 💬 Ustekinumab 💬 Ustekinumab 17件: 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
282 Inflammatory bowel disease 💬
 1件: IL17A 💬 Secukinumab 💬 Secukinumab 9件: 13, 37, 40, 41, 46, 107, 160, 269, 271 💬
283 Inflammatory bowel disease 💬
 1件: TNF 💬 Adalimumab 💬 Adalimumab 22件: 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
284 Inflammatory bowel disease 💬
 1件: TNF 💬 Certolizumab pegol 💬 Certolizumab pegol 10件: 37, 40, 46, 48, 49, 96, 97, 107, 226, 271 💬
285 Inflammatory bowel disease 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
286 Inflammatory mediator regulation of TRP channels 💬
 1件: IL1B 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
287 Influenza A 💬
 5件: CCL2, IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
288 Influenza A 💬
 2件: IL12A, IL12B 💬 Ustekinumab 💬 Ustekinumab 17件: 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
289 Influenza A 💬
 1件: JAK1 💬 Ivarmacitinib 💬 Ivarmacitinib 6件: 40, 46, 51, 56, 271, 300 💬
290 Influenza A 💬
 1件: JAK1 💬 Ivarmacitinib sulfate 💬 Ivarmacitinib 6件: 40, 46, 51, 56, 271, 300 💬
291 Influenza A 💬
 1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
292 Influenza A 💬
 1件: JAK1 💬 Upadacitinib tartrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
293 Influenza A 💬
 1件: JAK1 💬 Upadacitinib hydrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
294 Influenza A 💬
 2件: JAK1, JAK2 💬 Baricitinib 💬 Baricitinib 24件:  2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬
295 Influenza A 💬
 3件: JAK1, JAK2, TYK2 💬 Tofacitinib citrate 💬 Tofacitinib 23件:  2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
296 Influenza A 💬
 3件: JAK1, JAK2, TYK2 💬 Tofacitinib 💬 Tofacitinib 23件:  2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
297 Influenza A 💬
 1件: TNF 💬 Adalimumab 💬 Adalimumab 22件: 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
298 Influenza A 💬
 1件: TNF 💬 Certolizumab pegol 💬 Certolizumab pegol 10件: 37, 40, 46, 48, 49, 96, 97, 107, 226, 271 💬
299 Influenza A 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
300 Influenza A 💬
 1件: TYK2 💬 Deucravacitinib 💬 Deucravacitinib 10件: 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬
301 Insulin resistance 💬
 2件: IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
302 Insulin resistance 💬
 1件: TNF 💬 Adalimumab 💬 Adalimumab 22件: 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
303 Insulin resistance 💬
 1件: TNF 💬 Certolizumab pegol 💬 Certolizumab pegol 10件: 37, 40, 46, 48, 49, 96, 97, 107, 226, 271 💬
304 Insulin resistance 💬
 1件: TNF 💬 Infliximab 💬 Infliximab 27件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 107, 162, 164, 223, 269, 270, 271 💬
305 Intestinal immune network for IgA production 💬
 2件: IL10, IL6 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
306 JAK-STAT signaling pathway 💬
 1件: CSF3R 💬 Filgrastim 💬 Filgrastim 30件:  2 ,  6 , 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 63, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
307 JAK-STAT signaling pathway 💬
 2件: IL10, IL6 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
308 JAK-STAT signaling pathway 💬
 3件: IL12A, IL12B, IL23A 💬 Ustekinumab 💬 Ustekinumab 17件: 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬
309 JAK-STAT signaling pathway 💬
 1件: IL6R 💬 Tocilizumab 💬 Tocilizumab 26件:  2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 65, 86, 107, 149, 153, 223, 266, 271, 298, 331 💬
310 JAK-STAT signaling pathway 💬
 1件: JAK1 💬 Ivarmacitinib 💬 Ivarmacitinib 6件: 40, 46, 51, 56, 271, 300 💬
311 JAK-STAT signaling pathway 💬
 1件: JAK1 💬 Ivarmacitinib sulfate 💬 Ivarmacitinib 6件: 40, 46, 51, 56, 271, 300 💬
312 JAK-STAT signaling pathway 💬
 1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
313 JAK-STAT signaling pathway 💬
 1件: JAK1 💬 Upadacitinib tartrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
314 JAK-STAT signaling pathway 💬
 1件: JAK1 💬 Upadacitinib hydrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
315 JAK-STAT signaling pathway 💬
 2件: JAK1, JAK2 💬 Baricitinib 💬 Baricitinib 24件:  2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬
316 JAK-STAT signaling pathway 💬
 4件: JAK1, JAK2, JAK3, TYK2 💬 Tofacitinib citrate 💬 Tofacitinib 23件:  2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
317 JAK-STAT signaling pathway 💬
 4件: JAK1, JAK2, JAK3, TYK2 💬 Tofacitinib 💬 Tofacitinib 23件:  2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
318 JAK-STAT signaling pathway 💬
 1件: TYK2 💬 Deucravacitinib 💬 Deucravacitinib 10件: 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬
319 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: IL6 💬 Pirfenidone 💬 Pirfenidone 12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
320 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: JAK1 💬 Ivarmacitinib 💬 Ivarmacitinib 6件: 40, 46, 51, 56, 271, 300 💬
321 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: JAK1 💬 Ivarmacitinib sulfate 💬 Ivarmacitinib 6件: 40, 46, 51, 56, 271, 300 💬
322 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: JAK1 💬 Upadacitinib 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
323 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: JAK1 💬 Upadacitinib tartrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
324 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: JAK1 💬 Upadacitinib hydrate 💬 Upadacitinib 12件: 40, 41, 46, 49, 53, 55, 63, 96, 97, 98, 107, 271 💬
325 Kaposi sarcoma-associated herpesvirus infection 💬
 2件: JAK1, JAK2 💬 Baricitinib 💬 Baricitinib 24件:  2 , 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63,